Biopharmaceutical company licensing and developing drugs to treat fibrosis.

Sectors
Healthcare
Life Sciences
First Invested
2015
Early
Company Status
IPO/Acquired
NASDAQ: OKUR
Board Members
Edward Mathers
Website
Reneo Pharmaceuticals